Nasopharyngeal carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
**Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | **Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | ||
**[[Brachytherapy]] | **[[Brachytherapy]] | ||
*Undifferentiated subtype of nasopharyngeal carcinoma is highly radiosensitive | *Undifferentiated subtype of nasopharyngeal carcinoma is highly radiosensitive | ||
==References== | ==References== | ||
Revision as of 20:14, 17 September 2015
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma medical therapy |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The mainstay of therapy for nasopharyngeal carcinoma is external beam radiotherapy, supplemented in some cases with chemotherapy.
Medical Therapy
The mainstay of therapy for nasopharyngeal carcinoma is external beam radiotherapy
- Standard treatments for patients with nasopharyngeal carcinoma include:[1]
- External beamradiation therapy alone
- Concurrent chemoradiation followed by adjuvant chemotherapy
- Chemotherapy alone for metastatic disease
- Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following:[2]
- Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost
- Brachytherapy
- Undifferentiated subtype of nasopharyngeal carcinoma is highly radiosensitive
References
- ↑ http://www.cancer.gov/types/head-and-neck/hp/nasopharyngeal-treatment-pdq#section/_50
- ↑ Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE; et al. (1999). "Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control". Int J Radiat Oncol Biol Phys. 45 (4): 915–21. PMID 10571198.